Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
David Liberg0
Stephen East0
Natacha Prevost0
Colin Mackinnon0
Ingela Fritzson0
Date of Patent
January 23, 2018
Patent Application Number
14890938
Date Filed
May 14, 2014
Patent Primary Examiner
Patent abstract
A compound of formula (I), or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
